Ambrx, Inc.

AMBODY

Pharmaceutical preparations comprised of polypeptides for the treatment and/or prevention of human, animal and livestock diseases, namely, cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, and wound healing; pharmaceutical preparations comprised of polypeptides for imaging, namely, radiochemistry and bioconjugation agents for in vivo imaging; pharmaceutical preparations, namely, analgesics; vaccines; biological medical reagents for use in clinical and medical tests for the diagnosis and measurement of disease progression in human, animal and livestock diseases; biological medical reagents for use in clinical and medical imaging; vaccine adjuvants, namely, proteins for use in presenting antigens;AMBRX BODY;Enzymes for scientific and research purposes; biological reagents for research purposes for use in the development of monoclonal and polyclonal antibodies; biological reagents for research purposes used in laboratory, clinical and medical applications;

AMBRX

Research and development for others in the field of protein-based pharmaceutical and diagnostic agents, and protein-based assay reagents;

AMBRX

Biological and biochemical preparations for the treatment of cancer, namely, protein expression systems consisting of amino acids, enzymes, RNA molecules, and live cells for generating novel bio-therapeutics and optimizing the performance of bio-conjugated peptides, therapeutic proteins, monoclonal antibodies, and bi- and multi-specific medicines;

AMBRX

Development of new technology for others in the field of protein engineering; scientific research; industrial research in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology; research in genetic, medical, pharmaceutical and chemistry fields; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology; scientific research, namely, studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology;

CHEMICAL BIOTECHNOLOGY

Pharmaceutical drug development services;

PIONEERING PROTEIN MEDICINAL CHEMISTRY

PROTEIN MEDICINAL CHEMISTRY;Pharmaceutical drug development services;

PROTEIN MEDICINAL CHEMISTRY

Pharmaceutical drug development services;

TAGABODY

Pharmaceutical preparations comprised of polypeptides for the treatment and/or prevention of human, animal and livestock diseases, namely, cardiovascular disease, metabolic disease, autoimmune disease, diabetes, obesity, inflammatory disease, vascular disease, dermatological disease, ocular disease, hematological disease, neurological disease, gastrointestinal disease, respiratory disease, infectious disease, cancer, allergies, allograft rejection, genetic disorders, diseases of the musculoskeletal and nervous system, and wound healing; pharmaceutical preparations comprised of polypeptides for imaging, namely, radiochemistry and bioconjugation agents for in vivo imaging; pharmaceutical preparations, namely, analgesics; vaccines; biological medical reagents for use in clinical and medical tests for the diagnosis and measurement of disease progression in human, animal and livestock diseases; biological medical reagents for use in clinical and medical imaging; vaccine adjuvants, namely, proteins for use in presenting antigens;Enzymes for scientific and research purposes; biological reagents for research purposes for use in the development of monoclonal and polyclonal antibodies; biological reagents for research purposes used in laboratory, clinical and medical applications;The mark TAGABODY has no meaning in a foreign language.;